Product Information

BLEOMYCIN SULFATE 15 UNIT VIAL is a generic product labeled by Hospira Inc., priced at $26.4480 per EA under NDC 00409033220. Its NADAC has been published 88 times since Dec 18, 2024.

FDA first approved this application on Mar 10, 2000. Its Orange Book therapeutic-equivalence code is AP.

BLEOMYCIN SULFATE 15 UNIT VIAL

BLEOMYCIN
$26.4480per EA

Strength

15 [USP'U]/1

Manufacturer

Hospira Inc.

NDC

00409033220

Classification

Generic

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS

Effective Date

4/22/2026

Active Ingredients

BLEOMYCIN SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA065031

FDA Approved

3/10/2000

TE Code

AP

On Market Since

4/25/2015

Pharmacological Classes

Price Statistics

The NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has been published 88 times since Dec 18, 2024, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.

Current price$26.4480 per EA
All-time high$31.7820 (Dec 10, 2025)
All-time low$24.0040 (Dec 17, 2025)
52-week high$31.7820
52-week low$24.0040
Median price$31.7820
Average price$29.2065
Largest weekly change-24.5% (Dec 17, 2025)
Weeks tracked88
Tracking sinceDec 18, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+6.6%

1Y

-16.8%

3Y

N/A

5Y

N/A

All

-16.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of BLEOMYCIN SULFATE 15 UNIT VIAL?

The current National Average Drug Acquisition Cost (NADAC) for BLEOMYCIN SULFATE 15 UNIT VIAL, manufactured by Hospira Inc., is $26.4480 per EA (NDC 00409033220), effective Aug 19, 2026.

How has the price of BLEOMYCIN SULFATE 15 UNIT VIAL changed over time?

Over the history we have for it, the NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has declined 16.8%. It has been tracked across 88 weekly CMS publications since Dec 18, 2024.

What are the highest and lowest recorded NADAC prices for BLEOMYCIN SULFATE 15 UNIT VIAL?

Since Dec 18, 2024, the NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has ranged from a low of $24.0040 (Dec 17, 2025) to a high of $31.7820 (Dec 10, 2025), with a median of $31.7820 per EA.

Are there cheaper alternatives to BLEOMYCIN SULFATE 15 UNIT VIAL?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BLEOMYCIN SULFATE 15 UNIT VIAL in a comparable dosage form, but none are currently priced below it.

Who manufactures BLEOMYCIN SULFATE 15 UNIT VIAL?

BLEOMYCIN SULFATE 15 UNIT VIAL (NDC 00409033220) is labeled by Hospira Inc., and CMS classifies it as a generic product.